Berkeley HeartLab
This article was originally published in Start Up
Executive Summary
Diagnostics; Cardiovascular disease management. Berkeley HeartLab is focusing on improving cardiovascular risk assessment using unique blood tests which measure lipid abnormalities based on inherited traits. The company is also developing treatment algorithms which help a physician decide which course of therapy to prescribe for a particular patient.